Ethicon Buying SurgRx

Ethicon Endo-Surgery, a unit of Johnson & Johnson, has agreed to acquire SurgRx Inc., a Redwood City, Calif.-based developer of laparoscopic vessel fusion tools for surgical hemostasis. No financial terms were disclosed. SurgRx has raised around $83 million in total VC funding since 2003, from firms like Alta Partners, New Enterprise Associates, California Technology Ventures, Magnetar Capital Return, Prospect Venture Partners and Trellis Health Ventures.


Ethicon Endo-Surgery announced today that it has entered into a definitive agreement to acquire SurgRx, a privately held developer of the advanced bipolar tissue sealing system used in the EnSeal